Routine use of continuous glucose monitoring in 10 501 people with diabetes mellitus

Diabetic Medicine

Volumn 32, Issue 12, 2015, Pages 1568-1574

  Battelino, Tadej ^a,b   Liabat, S ^c   Veeze, H J ^d   Castaneda J ^e   Arrieta, A ^e   Cohen, O ^f  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Tolochenaz   (Switzerland)

^d Center for Pediatric and Adolescent Diabetes Care and Research   (Netherlands)

^e MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

^f SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HEALTH CARE UTILIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LONG TERM CARE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; REIMBURSEMENT; TREATMENT WITHDRAWAL; ADVERSE EFFECTS; AMBULATORY MONITORING; ANALYSIS; BLOOD; CANADA; CHEMICALLY INDUCED; CLINICAL PRACTICE; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG RESISTANCE; ECONOMICS; EUROPE; HYPERGLYCEMIA; INSULIN INFUSION; ISRAEL; MEDICAL INFORMATION SYSTEM; PATIENT COMPLIANCE; TIME FACTOR;

BLOOD GLUCOSE; CANADA; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG RESISTANCE; EUROPE; HEALTH INFORMATION EXCHANGE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; INSURANCE, HEALTH, REIMBURSEMENT; ISRAEL; MONITORING, AMBULATORY; PATIENT COMPLIANCE; PRACTICE PATTERNS, PHYSICIANS'; TIME FACTORS;

EID: 84954423620     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12825     Document Type: Article

References (25)

1. Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med 2012; 157: 336-347.
2. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010; 363: 311-320.
3. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN et al. Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care 2011; 34: 2403-2405.
4. Hermanides J, Nørgaard K, Bruttomesso D. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial. Diabet Med 2011; 28: 1158-1167.
5. Battelino T, Conget I, Olsen B, Schütz-Fuhrmann I, Hommel E, Hoogma R et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012; 55: 3155-3162.
6. Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011; 34: 795-800.
7. Conget I, Battelino T, Giménez M, Gough H, Castañeda J, Bolinder J et al. The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy. Diabetes Technol Ther 2011; 13: 49-54.
8. Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data. BMJ 2011; 343: d3805.
9. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013; 369: 224-232.
10. Ly TT, Nicholas JA, Retterath A, Lim EM, Davis EA, Jones TW. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. JAMA 2013; 310: 1240-1247.
11. Lodwig V, Kulzer B, Schnell O, Heinemann L. What are the next steps in continuous glucose monitoring? J Diabetes Sci Technol 2014; 8: 397-402.
12. Lodwig V, Kulzer B, Schnell O, Heinemann L. Current trends in continuous glucose monitoring. J Diabetes Sci Technol 2014; 8: 390-396.
13. Heinemann L, DeVries JH. Evidence for continuous glucose monitoring: sufficient for reimbursement? Diabet Med 2014; 31: 122-125.
14. Nørgaard K, Scaramuzza A, Bratina N, Lalić NM, Jarosz-Chobot P, Kocsis G et al. Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study. Diabetes Technol Ther 2013; 15: 273-280.
15. Cohen O, Körner A, Chlup R, Zoupas CS, Ragozin AK, Wudi K et al. Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: prospective results from a community and academic practice patient registry. J Diabetes Sci Technol 2009; 3: 804-811.
16. Altaf-Ul-Amin M, Afendi FM, Kiboi SK, Kanaya S. Systems biology in the context of big data and networks. Biomed Res Int 2014: 428570.
17. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study. Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010; 33: 17-22.
18. ™ database. Pediatr Endocrinol Rev 2010; 7(Suppl. 3): 413-416.
19. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31: 1473-1478.
20. Bland JM, Kerry SM. Statistics notes. Weighted comparison of means. BMJ 1998; 316: 129.
21. Pratley RE. The efficacy and effectiveness of drugs for diabetes: how do clinical trials and the real world compare? Diabetologia 2014; 57: 1273-1275.
22. Ahrén B, Mathieu C, Bader G, Schweizer A, Foley JE. Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies. Diabetologia 2014; 57: 1304-1307.
23. Pickup JC. The evidence base for diabetes technology: appropriate and inappropriate meta-analysis. J Diabetes Sci Technol 2013; 7: 1567-1574.
24. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749-755.
25. Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ et al. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care 2014; 37: 2702-2709.